|
1
|
Ruiz-Artacho P, Lecumberri R,
Trujillo-Santos J, Font C, Lopez-Nunez JJ, Peris ML, Pedroche CD,
Lobo JL, Jimenez LL, Reyes RL, et al: Cancer histology and natural
history of patients with lung cancer and venous thromboembolism.
Cancers (Basel). 14:41272022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hojbjerg JA, Bentsen KK, Vinholt PJ,
Hansen O, Jeppesen SS and Hvas AM: Increased in vivo thrombin
generation in patients with localized non-small cell lung cancer
unfit for surgery. Clin Appl Thromb Hemost.
29:107602962311528972023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lobo FT, Alves R, Judas T and Delerue MF:
Marantic endocarditis and paraneoplastic pulmonary embolism. BMJ
Case Rep. 2017:bcr20172202172017. View Article : Google Scholar
|
|
4
|
Lysov Z, Swystun LL, Kuruvilla S, Arnold A
and Liaw PC: Lung cancer chemotherapy agents increase procoagulant
activity via protein disulfide isomerase-dependent tissue factor
decryption. Blood Coagul Fibrinolysis. 26:36–45. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu B, Zhang J, Tang S, Hou J and Ma M:
Comparison of two types of catheters through femoral vein
catheterization in patients with lung cancer undergoing
chemotherapy: A retrospective study. J Vasc Access. 19:651–657.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dou F, Li H, Zhu M, Liang L and Zhang Y,
Yi J and Zhang Y: Association between oncogenic status and risk of
venous thromboembolism in patients with non-small cell lung cancer.
Respir Res. 19:882018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Davidsson E, Murgia N, Ortiz-Villalon C,
Wiklundh E, Skold M, Kolbeck KG and Ferrara G: Mutational status
predicts the risk of thromboembolic events in lung adenocarcinoma.
Multidiscip Respir Med. 12:162017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schattner A, Adi M, Kitroser E and
Klepfish A: Acute splenic infarction at an academic general
hospital over 10 years. Medicine (Baltimore). 94:e13632015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abdallah A, Kaur V, Mahmoud F and Motwani
P: Image diagnosis: Splenic infarction associated with oral
contraceptive pills in a healthy young woman. Perm J. 21:16–071.
2017. View Article : Google Scholar
|
|
10
|
He YA, Wang DX, Lin LJ and Zheng CQ:
Report of a case of splenic infarction and review of the
literature. J Gastroenterol Hepatol. 29:239–240. 2020.
|
|
11
|
Yin X, He T, Hu H, Sun J and Xu Y: Report
of a case of splenic arteriovenous embolism resulting in necrosis
of the stomach, spleen and pancreatic body tail. Chin J Mod
Operative Surg. 28:434–435. 2024.(In Chinese).
|
|
12
|
Brett AS, Azizzadeh N, Miller EM, Collins
RJ, Seegars MB and Marcus MA: Assessment of clinical conditions
associated with splenic infarction in adult patients. JAMA Intern
Med. 180:1125–1128. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang Q, Tang M, Chang X, He M, Liu Y and
Yin S: Construction and assessment of a Nomogram model for lung
cancer patients with concurrent deep vein thrombosis. Chinese
Journal of New Clinical Medicine. 17:1019–1025. 2024.(In
Chinese).
|
|
14
|
Square F, Fu XG and Li YB: Deep vein
thrombosis in the lower limbs of elderly lung cancer patients and
its influencing factors. J Pract Cancer. 39:612–614. 2024.
|
|
15
|
Di W, Xu H, Ling C and Xue T: Early
identification of lung cancer patients with venous thromboembolism:
Development and validation of a risk prediction model. Thromb J.
21:952023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X and Zhi X: Introduction to the 8th
edition of the TNM Classification of the Internatinoal Association
for the Study of Lung Cancer (IASLC). Chin J Tharac Surg. 3:70–76.
2016.(In Chinese).
|
|
17
|
Writing Expert Group National Expert
Committee on Capacity Building Project for Prevention and Treatment
of Pulmonary Embolism and Deep Vein Thrombosis: Quality Evaluation
and Management Guidelines for Prevention and Treatment of Venous
Thromboembolism in Hospitals (2022 Edition). Natl Med J China.
102:3338–3348. 2022.(In Chinese).
|
|
18
|
Li J, Yan S, Zhang X, Xiang M, Zhang C, Gu
L, Wei X, You C, Chen S, Zeng D and Jiang J: Circulating D-dimers
increase the risk of mortality and venous thromboembolism in
patients with lung cancer: A systematic analysis combined with
external validation. Front Med (Lausanne). 9:8539412022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanfilippo KM, Fiala MA, Feinberg D,
Tathireddy H, Girard T, Vij R, Di Paola J and Gage BF: D-dimer
predicts venous thromboembolism in multiple myeloma: A nested
case-control study. Res Pract Thromb Haemost. 7:1022352023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamanaka Y, Sawai Y and Nomura S:
Platelet-derived microparticles are an important biomarker in
patients with cancer-associated thrombosis. Int J Gen Med.
12:491–497. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin C, Xu XQ, He SD and Hong T: Clinical
analysis of 21 cases of splenic infarction. J Chin Acad Med Sci.
36:321–323. 2014.
|
|
22
|
Levy JH, Shaw JR, Castellucci LA, Connors
JM, Douketis J, Lindhoff-Last E, Rocca B, Samama CM, Siegal D and
Weitz JI: Reversal of direct oral anticoagulants: Guidance from the
SSC of the ISTH. J Thromb Haemost. 22:2889–2899. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao L, Duan Z, Zhang T, Yuan R and Wang G:
Progress of Study on Malignant Tumors and Thrombogenesis. Progress
in Modern Biomedicine. 16:2187–2190. 2016.(In Chinese).
|
|
24
|
Wei R: Risk factors and treatment analysis
of combined venous thromboembolism in lung cancer chemotherapy
patients. J Clin Med. 4:15085–15086. 2017.(In Chinese).
|
|
25
|
Khorana AA, Mackman N, Falanga A, Pabinger
I, Noble S, Ageno W, Moik F and Lee AYY: Cancer-associated venous
thromboembolism. Nat Rev Dis Primers. 8:112022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng Y, Cai X and Liu JW: Malignant
tumours and thrombosis. J Clin Oncol. 15:376–379. 2010.
|
|
27
|
Wang D, Xiong W and Han F: Advances in the
pathogenesis of venous thromboembolism associated with lung cancer.
Chinese Journal of Respiratory and Critical Care. 22:135–141.
2023.(In Chinese).
|
|
28
|
Zhang M, Wu S and Hu C: Do lung cancer
patients require routine anticoagulation treatment? A
meta-analysis. J Int Med Res. 48:3000605198969192020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Syrigos K, Grapsa D, Sangare R,
Evmorfiadis I, Larsen AK, Van Dreden P, Boura P, Charpidou A,
Kotteas E, Sergentanis TN, et al: Prospective assessment of
clinical risk factors and biomarkers of hypercoagulability for the
identification of patients with lung adenocarcinoma at risk for
cancer-associated thrombosis: The observational ROADMAP-CAT study.
Oncologist. 23:1372–1381. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang L, Liu XQ, Chen J, Bai Y, Li J, Zhang
YD and Liu QX: Reducing the incidence of postoperative venous
thromboembolism in patients with lung cancer. China Health Quality
Management. 28:66–70. 2021.(In Chinese).
|
|
31
|
Hao EE and Jia Q: Correlation between
coagulation function and tumour metastatic recurrence in non-small
cell lung cancer patients. Thromb Haemost. 28:967–969. 2022.
|
|
32
|
Cukic V and Ustamujic A: Lung cancer and
pulmonary thromboembolism. Mater Sociomed. 27:351–353. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takemoto T, Soh J, Ohara S, Fujino T, Koga
T, Nishino M, Hamada A, Chiba M, Shimoji M, Suda K, et al: The
prevalence and risk factors associated with preoperative deep
venous thrombosis in lung cancer surgery. Surg Today. 51:1480–1487.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meikle CK, Meisler AJ, Bird CM, Jeffries
JA, Azeem N, Garg P, Crawford EL, Kelly CA, Gao TZ, Wuescher LM, et
al: Platelet-T cell aggregates in lung cancer patients:
Implications for thrombosis. PLoS One. 15:e02369662020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Minnelli C, Cianfruglia L, Laudadio E,
Mobbili G, Galeazzi R and Armeni T: Effect of
epigallocatechin-3-Gallate on EGFR signaling and migration in
non-small cell lung cancer. Int J Mol Sci. 22:118332021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Saryeddine L, Zibara K, Kassem N, Badran B
and El-Zein N: EGF-induced VEGF exerts a PI3K-dependent positive
feedback on ERK and AKT through VEGFR2 in hematological in vitro
models. PLoS One. 11:e01658762016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hamza MS and Mousa SA: Cancer-Associated
thrombosis: Risk factors, molecular mechanisms, future management.
Clin Appl Thromb Hemost. 26:10760296209542822020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Akinbo DB and Ajayi OI: Thrombotic
pathogenesis and laboratory diagnosis in cancer patients, an
update. Int J Gen Med. 16:259–272. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xiao M, Pang C, Xiang S, Zhao Y, Wu X, Li
M, Du F, Chen Y, Wang F, Wen Q, et al: Comprehensive
characterization of B7 family members in NSCLC and identification
of its regulatory network. Sci Rep. 13:43112023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Durica SS: Venous thromboembolism in the
cancer patient. Curr Opin Hematol. 4:306–311. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen P, Wan G and Zhu B: Incidence and
risk factors of symptomatic thrombosis related to peripherally
inserted central catheter in patients with lung cancer. J Adv Nurs.
77:1284–1292. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Feng Y, Fu Y, Xiang Q, Xie L, Yu C and Li
J: Plasminogen activator inhibitor-1 gene promoter 4G/5G
polymorphism and risks of peripherally inserted central
catheter-related venous thrombosis in patients with lung cancer: A
prospective cohort study. Support Care Cancer. 29:6431–6439. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gao S, Sun S and Song J: Recent advances
in the pathogenesis and treatment of malignant pericardial
effusion. China Research Hospitals. 12:62–67. 2025.(In
Chinese).
|
|
44
|
Hu YX, Jiang Y, Yan J and Liu JL:
Treatment and prognosis of lung cancer with malignant pericardial
effusion in emergency setting. Acad J Sec Mil Med Univ. 30:583–585.
2009. View Article : Google Scholar
|
|
45
|
Suwanwongse K and Shabarek N: Atrial
flutter as an initial presentation of malignant pericardial
effusion caused by lung cancer. Cureus. 12:e117122020.PubMed/NCBI
|
|
46
|
Dequanter D, Lothaire P, Berghmans T and
Sculier JP: Severe pericardial effusion in patients with concurrent
malignancy: A retrospective analysis of prognostic factors
influencing survival. Ann Surg Oncol. 15:3268–3271. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sundar R, Soong R, Cho B, Brahmer JR and
Soo RA: Immunotherapy in the treatment of non-small cell lung
cancer. Lung Cancer. 85:101–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Vakamudi S, Ho N and Cremer PC:
Pericardial effusions: Causes, diagnosis, and management. Prog
Cardiovasc Dis. 59:380–388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qiu J, Xu L, Zeng X, Wu Z, Wang Y, Wang Y,
Yang J, Wu H, Xie Y, Liang F, et al: NUSAP1 promotes the metastasis
of breast cancer cells via the AMPK/PPARgamma signaling pathway.
Ann Transl Med. 9:16892021. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hu ZG, Hu K, Li WX and Zeng FJ: Prognostic
factors and nomogram for cancer-specific death in non small cell
lung cancer with malignant pericardial effusion. PLoS One.
14:e02170072019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Goel K, Ateeli H, Ampel NM and L'Heureux
D: Patient with small cell lung carcinoma and suspected right upper
lobe abscess presenting with a purulent pericardial effusion. Am J
Case Rep. 17:523–528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chiruvella V, Ullah A, Elhelf I, Patel N
and Karim NA: Would the addition of immunotherapy impact the
prognosis of patients with malignant pericardial effusion? Front
Oncol. 12:8711322022. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Krolczyk G, Zabczyk M, Czyzewicz G, Plens
K, Prior S, Butenas S and Undas A: Altered fibrin clot properties
in advanced lung cancer: Impact of chemotherapy. J Thorac Dis.
10:6863–6872. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Koyama N, Tomoda K, Matsuda M, Fujita Y,
Yamamoto Y, Hontsu S, Tasaki M, Yoshikawa M and Kimura H: Acute
bilateral renal and splenic infarctions occurring during
chemotherapy for lung cancer. Intern Med. 55:3635–3639. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wang YL and Fan XZ: A case of splenic
infarction initiated by upper abdominal pain. Clinical Focus.
29:209–210. 2014.(In Chinese).
|
|
56
|
Grant-Freemantle MC, Bass GA, Butt WT and
Gillis AE: Splenectomy for isolated splenic metastasis from primary
lung adenocarcinoma. BMJ Case Rep. 13:e2332562020. View Article : Google Scholar : PubMed/NCBI
|
